Metabolic interactions are not expected since itopride is primarily metabolized by flavine monooxygenase & not by CYP450. May influence the absorption of concomitantly orally administered drugs. Particular caution should be taken w/ a narrow therapeutic index, SR or EC formulations. Reduced action w/ anticholinergics.